Among SSc-associated autoantibodies, anti-CENP-B antibody, anti-topoisomerase I antibody, and anti-RNA polymerase III (RPC155) antibody were commonly detected in SSc patients, with the prevalence rate of 32.2%, 26.9%, and 11.2%, respectively. This evidence concerns the gene POLR3A and systemic sclerosis.